These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25742668)

  • 1. Using "clinical trial diaries" to track patterns of participation for serial healthy volunteers in U.S. phase I studies.
    Edelblute HB; Fisher JA
    J Empir Res Hum Res Ethics; 2015 Feb; 10(1):65-75. PubMed ID: 25742668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I trial compensation: How much do healthy volunteers actually earn from clinical trial enrollment?
    Fisher JA; McManus L; Kalbaugh JM; Walker RL
    Clin Trials; 2021 Aug; 18(4):477-487. PubMed ID: 33938244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. To report or not to report: Exploring healthy volunteers' rationales for disclosing adverse events in Phase I drug trials.
    McManus L; Fisher JA
    AJOB Empir Bioeth; 2018; 9(2):82-90. PubMed ID: 29693508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthy volunteers' perceptions of risk in US Phase I clinical trials: A mixed-methods study.
    Fisher JA; McManus L; Cottingham MD; Kalbaugh JM; Wood MM; Monahan T; Walker RL
    PLoS Med; 2018 Nov; 15(11):e1002698. PubMed ID: 30457992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthy Volunteers' Perceptions of the Benefits of Their Participation in Phase I Clinical Trials.
    Fisher JA; McManus L; Wood MM; Cottingham MD; Kalbaugh JM; Monahan T; Walker RL
    J Empir Res Hum Res Ethics; 2018 Dec; 13(5):494-510. PubMed ID: 30296882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "My Body is One of the Best Commodities": Exploring the Ethics of Commodification in Phase I Healthy Volunteer Clinical Trials.
    Walker RL; Fisher JA
    Kennedy Inst Ethics J; 2019; 29(4):305-331. PubMed ID: 31983696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase 1 healthy volunteer willingness to participate and enrollment preferences.
    Chen SC; Sinaii N; Bedarida G; Gregorio MA; Emanuel E; Grady C
    Clin Trials; 2017 Oct; 14(5):537-546. PubMed ID: 28766409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appraising Harm in Phase I Trials: Healthy Volunteers' Accounts of Adverse Events.
    McManus L; Davis A; Forcier RL; Fisher JA
    J Law Med Ethics; 2019 Jun; 47(2):323-333. PubMed ID: 31298107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthy volunteers in US phase I clinical trials: Sociodemographic characteristics and participation over time.
    Kalbaugh CA; Kalbaugh JM; McManus L; Fisher JA
    PLoS One; 2021; 16(9):e0256994. PubMed ID: 34492044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial Participation and the Ethics of Phase 1 Healthy Volunteer Research.
    Walker RL; Cottingham MD; Fisher JA
    J Med Philos; 2018 Jan; 43(1):83-114. PubMed ID: 29342285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stopped hearts, amputated toes and NASA: contemporary legends among healthy volunteers in US phase I clinical trials.
    Fisher JA
    Sociol Health Illn; 2015 Jan; 37(1):127-42. PubMed ID: 25601069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeat participation among normal healthy research volunteers: professional guinea pigs in clinical trials?
    Tishler CL; Bartholomae S
    Perspect Biol Med; 2003; 46(4):508-20. PubMed ID: 14593220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Picking and Choosing Among Phase I Trials : A Qualitative Examination of How Healthy Volunteers Understand Study Risks.
    Fisher JA; Monahan T; Walker RL
    J Bioeth Inq; 2019 Dec; 16(4):535-549. PubMed ID: 31713712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I clinical trials of anticancer drugs in healthy volunteers: need for critical consideration.
    Gupta P; Gupta V; Gupta YK
    Indian J Pharmacol; 2012; 44(4):540-2. PubMed ID: 23087528
    [No Abstract]   [Full Text] [Related]  

  • 15. Motivations, enrollment decisions, and socio-demographic characteristics of healthy volunteers in phase 1 research.
    Grady C; Bedarida G; Sinaii N; Gregorio MA; Emanuel EJ
    Clin Trials; 2017 Oct; 14(5):526-536. PubMed ID: 28783972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motivation for participating in phase 1 vaccine trials: Comparison of an influenza and an Ebola randomized controlled trial.
    Cattapan A; Browne K; Halperin DM; Di Castri A; Fullsack P; Graham J; Langley JM; Taylor BA; McNeil SA; Halperin SA
    Vaccine; 2019 Jan; 37(2):289-295. PubMed ID: 30528592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Informal professionalization of healthy participants in phase I clinical trials in Russia.
    Zvonareva O; Pimenov I; Kutishenko N; Mareev I; Martsevich S; Kulikov E
    Clin Trials; 2019 Dec; 16(6):563-570. PubMed ID: 31647322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Study on the Characteristics of Healthy Volunteers who Participate in Phase I Clinical Trials in Korea.
    Seo JH; Kim OJ; Yoo SH; Choi EK; Park JE
    J Empir Res Hum Res Ethics; 2022; 17(1-2):193-212. PubMed ID: 34414819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qualitative study investigating the underlying motivations of healthy participants in phase I clinical trials.
    Manton KJ; Gauld CS; White KM; Griffin PM; Elliott SL
    BMJ Open; 2019 Jan; 9(1):e024224. PubMed ID: 30647042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enrollment of racial/ethnic minorities in NIAID-funded networks of HIV vaccine trials in the United States, 1988 to 2002.
    Djomand G; Katzman J; di Tommaso D; Hudgens MG; Counts GW; Koblin BA; Sullivan PS
    Public Health Rep; 2005; 120(5):543-8. PubMed ID: 16224987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.